Biocryst reports inducement grants under nasdaq listing rule 5635(c)(4)

Research triangle park, n.c., jan. 06, 2025 (globe newswire) -- biocryst pharmaceuticals, inc. (nasdaq: bcrx) today announced that the compensation committee of biocryst's board of directors granted 10 newly-hired employees stock options to purchase an aggregate of 52,750 shares, and restricted stock units (rsus) covering an aggregate of 36,975 shares, of biocryst common stock. the options and rsus were granted as of december 31, 2024, as inducements material to each employee entering into employment with biocryst. the options and rsus were granted in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking